A17.Aydın S, Çaylan R, Aydın K, Yuluğ E, Yenilmez E, Köksal I. The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue. J Natl Med Assoc 97;1489-95.
A18. Kolayli F, Gacar G, Karadenizli A, Sanic A, Vahaboglu H, The Study Group (Ozay Arikan Akan, Bekir Kocazeybek, Bulent Sumerkan, Rahmet Caylan, Halil Kurt, Hakan Leblebicioglu, Sercan Ulusoy). PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp. FEMS Microbiol Letters 2005;249:241-5.
A19. Sucu N, Caylan R, Kemalettin Aydın, Gürdal Yılmaz, Gönülden Aktoz Boz, İftihar Köksal. Prospective evaluation of blood cultures in medical faculty hospital of Blacksea Technical University. Mikrobiyol Bult 2005;39 (4):455-64.
A20. Hosoglu S, Esen S, Ozturk R, Altindis M, Ertek M, Kaygusuz S, Caylan R, Demirdag K, Sencan I, Ertem GT, Aslan S, Bosnak V, Aygun P, Erol S, Celen MK. The effect of a restriction policy on the antimicrobial consumption in Turkey: a country-wide study. Eur J Clin Pharmacol. 2005 ;61(10):727-31.
A21. Usluer G, Ozgunes I, Leblebicioglu H, Group S. A multicenter point prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey.
Ann Clin Microbiol Antimicrob. 2005 Oct 3;4(1):16.
A22. Arslan H, Azap OK, Ergonul O, Timurkaynak F on behalf of the Urinary Tract Infection Study Group (Participants of the Urinary Tract Infection Study Group are as follows: K. Aydın, M. Bakır, N. Balaban, N. Baykam, U. Cagır, R. Caylan, N. Elaldı, H. Erdogan, M. Fincancı, R. Hasimoglu, A. Izat, O. Karabay, S. Karaman, B. Mutlu, C.Ozakın, D.Ozdemir, E. Parlak, M. Parlak, I. Sencan, K. Serefhanoglu, M. Sınırtas, F. Sırmatel, M. Tasbakan, H. Turan, T. Turuncu, S. Ulusoy, H. Uncu and A. Willke-Topcu). Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005; 56:914-8.
Dostları ilə paylaş: |